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Abstract
Acute central chest pain accounts for a significant proportion 
of emergency medical admissions. If chest pain evaluation is 
systematic & risk-based, it may prevent unnecessary admissions. 
This audit aims to observe various aspects of management 
of patients admitted with chest pain; areas needing review 
are identified and improvements on current practice are 
considered.
 The study observed the current practices in 292 admissions 
for chest pain to the Medical Admissions Unit over a 3 month 
period. The relative frequency of risk factors and utilisation 
of resources were observed. Ninety-one patients (31.2%) that 
were admitted with chest pain had a diagnostic ECG or raised 
cardiac enzymes. Twenty-one patients (7.2%) had an urgent 
exercise stress test (EST) whilst 27 patients (9.2%) had an 
urgent coronary angiogram. In all, 16 patients (5.5 %) were re-
admitted with a cardiac event and 8 patients (2.7%) died within 
3 months. The presence of age >65, diabetes or hypertension 
were associated with a high rate of adverse events (13.9%, 16.4%, 
and 11.6% respectively).
* corresponding author
Introduction
Management of patients presenting with chest pain is a 
difficult process. Whereas diagnostic electrocardiogram (ECG) 
changes including ST changes and significant arrhythmias 
and elevated cardiac enzymes identify those with acute 
cardiac pathology, a considerable majority of patients have an 
indeterminate ECG and normal cardiac enzymes. An audit of 
the current practice was carried out. 
The objective of the initiative was to observe various 
aspects of management of patients admitted with chest pain 
to the Medical Admissions Unit (MAU). Areas needing review 
were identified and improvements on current practice were 
considered.
Method
Two hundred and ninety-two patients that were admitted 
with chest pain in the MAU between April and June 2007 were 
studied, using data from the MAU database, PAS and designated 
data sheets.
Analysis
Demographic features of the population group were 
gathered. Risk stratification was carried out for each patient 
based on age, symptoms, known risk factors, ECG findings and 
cardiac enzymes. Length of stay and utilisation of resources 
were observed. Adverse outcomes were recorded in terms 
of readmissions with cardiac events and mortality within 3 
months.
Conclusions derived from the data were used to appraise 
current practice and discuss the feasibility of implementing 
appropriate changes. 
Results 
The results of the study are presented as follows:
• Risk Factors
• ECG and Cardiac Enzymes
• Resources and Special Investigations
• Outcomes
Risk factors 
The commonest risk factors were hypertension, history of 
ischaemic heart disease (IHD) and smoking (Figure 1).
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ECG monitoring
Fifty-six patients (19.2%) were put on continuous ECG 
monitoring, of which 6/56 (10.7%) were found to have an 
arrhythmia. Conversely 4/5 of patients admitted with chest 
pain were not monitored.
Exercise stress ECG 
Only 21 patients (7.2%) had an EST, during admission, most 
of which (20/21, 95.2%) were negative. This essential screening 
tool was underutilised. Although many patients would have had 
an EST booked on discharge, elective EST did not facilitate a 
safe discharge in patients at risk who had negative ECG and 
enzymes.
Coronary angiography 
A significant number of patients (n=27, 9.2%) had an 
angiogram performed in the first 72 hours, of which a significant 
proportion (23/27, 85.2%) were negative.
CT scan thorax 
Only 2 patients (0.7%) had a CT Thorax, of which one was 
positive.
Figure 3: Percentage of diagnostic ECG/CK 
vs non-diagnostic ECG/CK
ECG and cardiac enzymes
One hundred and eighty-six patients (63.7%) had a normal 
ECG. 70 patients (23.9%) had a diagnostic ECG (defined as 
ST elevation/depression or arrhythmia). The rest had non-
diagnostic ECG changes (Q waves, T wave changes, LVH) 
(Figure 2). 
Thirty-six patients (12.3%) were found to have elevated 
cardiac enzymes (creatine phosphokinase: CPK).
Ninety-one patients (31.2%) had diagnostic ECG changes 
(ST changes, or arrhythmia) and/or elevated cardiac enzymes. 
Of the patients with diagnostic ECG/enzymes, 15 (16.5%) 
patients had both diagnostic ECG and elevated enzymes, 55 
(60.4%) patients had diagnostic ECG only and 21 (23.1%) had 
elevated cardiac enzymes only.
Therefore 1/3 of patients had a clear diagnosis of a cardiac 
event (acute coronary syndrome or a significant cardiac 
arrhythmia) whilst 2/3 of patients could not be diagnosed on 
the basis of ECG or cardiac enzymes (Figure 3).
Resources and special investigations
Figure 4 shows the distribution of the number of patients 
that were monitored or had a special investigation during their 
stay in the MAU. The relatively low use of echocardiography, 
ventilation perfusion (V/Q) scan and CT thorax was noted. 
Figure. 1. Distribution of of risk factors
FHx: family history; CVA: cerebrovascular accident, 
TIA: transient ischaemic attack, PVD: peripheral vascular disease
Number of Patients
Figure 2: Number of ECG changes in patients presenting 
with chest pain 
Number of Patients
Number of Patients
Figure 4: Distribution of resources utilised during 
admission to the MAU
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Pulmonary ventilation perfusion scan
11 patients (3.8%) had a V/Q scan, of which 4/11 
(36.4 %) were positive. Thus although few V/Q scans were 
done for patients presenting with chest pain, more than 1/3 
were positive.
Echocardiography
8 patients (2.7%) had an echocardiogram, one fourth of 
which (2/8, 25%) were abnormal.
EST vs. angiography
More angiograms (27) were carried out during admission 
than ESTs (21) (Figure 5).
Outcomes
Rate of admission vs. discharge
One hundred and twenty-nine patients (44.2%) were 
discharged from MAU. More than half of the patients (n=159, 
54.4%) were admitted to medical wards for further evaluation. 
A small percentage (n=4, 1.4%) was transferred to the Coronary 
Care Unit (CCU).
Distribution of length of stay 
Most patients spent 1 or 2 days in MAU. Roughly, half the 
patients staying 1 or 2 days were either discharged or transferred 
to the wards (Figure 6). A smaller number stayed 3 days or more 
and most of these patients were transferred to the wards.
Figure 8: Rate of adverse events (readmissions and 
mortality) at 3 months in patients admitted with chest 
pain to the MAU
Figure 7 compares the number of patients who were 
not diagnosed by ECG/CPK with the number of those who 
underwent an in-patient EST. An urgent EST could potentially 
have helped in the former group.
Adverse events (re-admission with cardiac event or mortality) 
at 3 months
Sixteen patients (5.5%) were re-admitted with a cardiac 
event and 8 patients (2.7%) died within 3 months, giving a total 
adverse event rate at 3 months of 8.2% (n=24) (Figure 8).
In 3 months, 4.7% (6/129) of patients that were discharged 
home from the MAU had an adverse event in 3 months whilst 
11.0% (18/163) of patients that were transferred to the wards 
for further evaluation suffered an adverse event.
Figure 9 shows the contribution of risk factors to the 
likelihood of re-admission. The biggest single risk factor giving 
the highest rate of adverse events at 3 months was diabetes 
(10/61, 16.4%). 
Discussion
This study was aimed at reviewing the current practice with 
regards to the local management of chest pain in the (MAU). 
Standardisation of clinical management is best achieved in a 
single dedicated unit that is run by medical and nursing staff that 
is well accustomed to the management of these symptoms.1 
Figure 5: Comparison of number of EST and angiograms 
carried during stay on the MAU
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Figure 7: Number of EST carried out at the MAU 
compared to number of patients with nondiagnostic 
ECG/CK
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Figure 6: Duration of stay and outcome
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Standardised care that combines efficiency and safety 
requires the implementation of guidelines that are used 
internationally. Such guidelines exist and have been validated in 
clinical trials.2-5  However, the implementation of these guidelines 
needs to be tested locally, mainly to assess feasibility. 
This study observes various facets of managing patients with 
chest pain, which can be analysed individually. The distribution 
of risk factors (Figure 1), shows hypertension, history of IHD 
and smoking as the commonest risk factors. It is pertinent to 
note that a significant proportion of patients with chest pain 
had a history of IHD. This means that the population of patients 
admitted with chest pain is a biased sample of the general 
population. They are at risk of cardiac events irrespective 
of the ECG or cardiac enzymes on presentation. This group 
of patients is a special group, because investigations are not 
targeted towards diagnosis (they have already been diagnosed 
with IHD), but rather represent a group of patients that require 
adjustments in their medical treatment or a decision to intervene 
(PCI or CABG).
ECG changes were common and found in 36.3% (n=106) of 
patients admitted with chest pain (Figure 2). However only circa 
one fourth (n=70, 23.9%) had a diagnostic ECG (ST elevation/
depression or arrhythmia) and 12.3% (n=36) had elevated 
cardiac enzymes. 
Thus, serious cardiac pathology could be diagnosed in 
only 31.2% (n=91) on the basis of ECG and cardiac enzymes 
(Figure 3). CPK was the cardiac enzyme used. This leaves 
approximately 2/3 of patients without a clear diagnosis based 
on ECG and cardiac enzymes. These patients would benefit from 
an algorithm for safe discharge.
This study observed the use of resources (Figure 4) whilst 
the patients were in the MAU, namely cardiac monitoring, EST 
and the use of special imaging techniques (angiogram, V/Q scan, 
echocardiography or CT Thorax). 
Continuous cardiac ECG monitoring was carried out in 1/5 
of patients and of these, a significant arrhythmia was detected 
in 10.7% (6/56). In other words, 1 in 5 patients were monitored, 
of which 1 in 10 had an arrhythmia. Ideally, all patients with 
Figure 9: Rate of adverse events (readmissions and 
mortality) at 3 months in the presence of a cardiovascular 
risk factor
Summary of results 
Risk factors
• The commonest risk factors were Hypertension, history 
of IHD and smoking.
ECG and cardiac enzymes
• The commonest ECG abnormalities were ST 
Depressions (n=45, 15.4%) and T wave flattening/
inversions (n=44, 15.1%). 
• 70 patients (23.9%) had a diagnostic ECG (ST changes 
or arrhythmia)
• 36 patients (12.3%) were found to have elevated cardiac 
enzymes (CPK). 
• 15 (16.5%) patients had both diagnostic ECG and 
elevated enzymes, 
• 55 (60.4%) patients had diagnostic ECG only and 
• 21 (23.1%) had elevated enzymes only.
• 1/3 of patients (n=91, 31.2%) had a clear diagnosis 
of acute coronary syndrome or a significant cardiac 
arrhythmia based on ECG/cardiac enzymes.
Resources and special investigations
• 1 in 5 had continuous ECG monitoring (n=56, 19.2%), 
of which 1/10th  had a documented arrhythmia (6/56, 
10.7%).
• 21 patients (7.2%) had an urgent EST, most of which 
(20/21, 95.2%) were negative.
• 27 patients (9.2%) had an angiogram performed during 
admission i.e. in the first 72 hours, most of which 
(23/27, 85.2%) were negative.
• 11 patients (3.8%) had a V/Q scan, of which, more than 
one third were positive (4/11, 36.4 %).
• 8 patients (2.7%) had an echocardiogram, 3/4 of which 
were negative (6/8, 75%).
• Urgent angiography (within 72 hours) was more 
utilised than urgent EST.
Outcomes and adverse events 
• More than half of the patients were transferred to 
medical wards for further evaluation.
• 247 patients (84.5%) spent 1 or 2 days in the MAU.
• 16 patients (5.5%) were re-admitted with a cardiac 
event and 8 patients (2.7%) died within 3 months, 
giving a total adverse event rate at 3 months of 8.2% 
(n=24).
• Adverse events in 3 months occurred in 4.7% (6/129) of 
patients that were discharged home from the MAU and 
in 11.0% (18/163) of patients that were transferred to 
wards for further investigation.
• The single risk factor giving the highest rate of adverse 
events at 3 months was diabetes (10/61, 16.4%).
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chest pain should be monitored. Clearly, logistics will not allow 
this and prioritisation will always be required, though more 
monitoring services would improve the standard of care. Despite 
the logistic limitations, the pick up rate of arrhythmias (6/56, 
10.7%) was significant indicating that the choice of patients that 
were monitored was appropriate.
The number of ESTs carried out before discharge was 
extremely low. Only 7.2% (n=21) had an EST before discharge, 
of which 95.2% (20/21) were negative. This is the most evident 
observation especially when comparing with the rate of coronary 
angiography. More urgent angiograms, (85.2% of which were 
normal) than urgent EST were performed (n=27, 9.2% vs. 
n=21, 7.2%, respectively). Exercise ECG testing increases the 
diagnostic value of the chest pain algorithm protocol when 
combined with serial enzymes and resting ECG.6
Three special imaging studies (CT Thorax, V/Q scan and 
echocardiogram) are useful in identifying alternative causes 
for chest pain. CT Thorax was rarely used. Significantly, of the 
3.8% (n=11) that had a V/Q scan, 36.4% (4/11) were positive. 
The low utilisation of V/Q scanning combined with the very 
high yield suggests an efficient use of this resource, though the 
safety of this possible underutilisation needs further evaluation. 
Only 2.7% (n=8) had an echocardiogram. Echocardiography 
is a noninvasive investigation that can be useful in evaluating 
chest pain. It can exclude pericardial effusions, detect global 
contractility dysfunctions indicating a possible myocarditis or 
regional abnormalities indicating ischaemia. The current ‘rule 
out MI’ approach to the management of chest pain tends to 
minimise the importance of other causes of chest pain.
Figure 7 compares the number of patients with non-
diagnostic ECG/cardiac enzymes with the number of urgent 
EST. This is the group where an urgent EST prior to discharge 
would have helped identify the medium and high risk patients 
that need admission and further work up, from the low risk 
patients that can be evaluated on an outpatient basis. 
This study observed the safety of the current discharge 
practices. This was measured in numbers of adverse events i.e. 
re-admission with cardiac events or mortality within 3 months 
of admission to MAU. Overall 8.2% (n=24) had an adverse event 
within 3 months (Figure 8). Most likely this represents a group 
of patients with significant morbidity prior to admission. 
Although decisions to admit patients for further evaluation 
to medical wards identified a high risk group of patients (11% 
adverse event rate) those that were discharged nevertheless 
suffered a significant 4.7% adverse event rate. An urgent EST 
may have identified high risk patients within this group. 
Logistic constraints would necessitate prioritisation for 
urgent EST, based on cardiac risk factors. The study (Figure 9) 
clearly shows the impact of the various cardiac risk factors on 
the rate of adverse events at 3 months.  As would be expected, 
age >65y (13.9%), diabetes (16.4%) and hypertension (11.6%) 
were the most predictive of adverse events. 
Conclusions
This study looked closely at the current practice with regard 
to the management of patients presenting with chest pain in the 
MAU. ECG and cardiac enzymes can diagnose 1/3 of patients, 
leaving 2/3 of patients that are being managed in a variable way. 
More than half are admitted for longer stays in hospital. Despite 
this, there is a significant rate of adverse events within 3 months. 
More continuous ECG monitoring facilities are required. 
Urgent EST is underutilised whereas urgent angiography 
is over utilised.  Urgent targeted bedside echocardiography 
provides key information and should be more widely available. 
The pick up rate for V/Q scan is high but utilisation is low. 
Although efficient, the safety of this practice needs to be studied 
further. 
Overall, patients are spending an average of 2 days in MAU. 
The implementation of a clinical algorithm that includes a lower 
threshold for in-patient EST may reduce this stay safely to 1 day 
or less for low to medium risk patients and may reduce requests 
for urgent angiography.
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